Abdelaziz EZ, AMS H BA, Bayomy NA, Rabat AE, Fawzy MS (2016) Potential anti-angiogenic effect of a combination of boswellic acids and cisplatin against chemically-induced colon cancer in mice. J Chem Biol Ther 1(02):406–2572

Google Scholar 

Adhami VM, Malik A, Zaman N, Sarfaraz S, Siddiqui IA, Syed DN, Afaq F, Pasha FS, Saleem M, Mukhtar H (2007) Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo. Clin Cancer Res 13(5):1611–1619

Article  CAS  PubMed  Google Scholar 

Ahmed SA, Al-Shanon AF, Al-Saffar AZ, Tawang A, Al-Obaidi JR (2023) Antiproliferative and cell cycle arrest potentials of 3-O-acetyl-11-keto-β-boswellic acid against MCF-7 cells in vitro. J Genet Eng Biotechnol 21(1):75

Article  PubMed  PubMed Central  Google Scholar 

Akil A, Gutiérrez-García AK, Guenter R, Rose JB, Beck AW, Chen H, Ren B (2021) Notch signaling in vascular endothelial cells, angiogenesis, and tumor progression: an update and prospective. Front Cell Dev Biol 9:177

Article  Google Scholar 

Al Salhi Y, Sequi MB, Valenzi FM, Fuschi A, Martoccia A, Pietro SP, Carbone A, Tema G, Lombardo R, Cicione A (2023) Cancer stem cells and prostate cancer: a narrative review. Int J Mol Sci 24(9):7746

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alam N, Qayum A, Kumar A, Khare V, Sharma PR, Andotra SS, Singh SK, Koul S, Gupta PN (2016) Improved efficacy of cisplatin in combination with a nano-formulation of pentacyclic triterpenediol. Mater Sci Eng C 68:109–116

Article  CAS  Google Scholar 

Alam K, Al-Riyami K, Csuk R, Arefian E, Al-Harrasi A (2022) Comparative study of the cytotoxicity, apoptotic, and epigenetic effects of Boswellic acid derivatives on breast cancer. Sci Rep 12(1):19979

Article  PubMed  PubMed Central  Google Scholar 

Al-Bahlani S, Burney IA, Al-Dhahli B, Al-Kharusi S, Al-Kharousi F, Al-Kalbani A, Ahmed I (2020) Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway. BMC Pharmacol Toxicol 21:1–10

Article  Google Scholar 

Amable L (2016) Cisplatin resistance and opportunities for precision medicine. Pharmacol Res 106:27–36

Article  CAS  PubMed  Google Scholar 

Ayaz M, Nawaz A, Ahmad S, Mosa OF, Eisa Hamdoon AA, Khalifa MA, Sadiq A, Ullah F, Wadood A, Kabra A (2022) Underlying anticancer mechanisms and synergistic combinations of phytochemicals with cancer chemotherapeutics: potential benefits and risks. J Food Qual 2022:1–15

Article  Google Scholar 

Bahmad HF, Demus T, Moubarak MM, Daher D, Alvarez Moreno JC, Polit F, Lopez O, Merhe A, Abou-Kheir W, Nieder AM (2022) Overcoming drug resistance in advanced prostate cancer by drug repurposing. Med Sci 10(1):15

CAS  Google Scholar 

Beldar VG, Jadhao M, Laddha K (2022) Development of a simple, rapid, and economical method for extraction and isolation of 3-O-acetyl-11-keto-β-boswellic acid from the resins of Boswellia serrata. Curr Bioact Compd 18(8):94–100

Article  Google Scholar 

Boice A (1867) Bouchier-Hayes L (2020) Targeting apoptotic caspases in cancer. Biochim Biophys Acta (BBA)-Molecular Cell Res 6:118688

Google Scholar 

Brown A, Kumar S, Tchounwou PB (2019) Cisplatin-based chemotherapy of human cancers. J Cancer Sci Ther. 11(4):97

PubMed  PubMed Central  Google Scholar 

Büchele B, Zugmaier W, Estrada A, Genze F, Syrovets T, Paetz C, Schneider B, Simmet T (2006) Characterization of 3α-acetyl-11-keto-α-boswellic acid, a pentacyclic triterpenoid inducing apoptosis in vitro and in vivo. Planta Med 72(14):1285–1289

Article  PubMed  Google Scholar 

Carneiro BA, El-Deiry WS (2020) Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 17(7):395–417

Article  PubMed  PubMed Central  Google Scholar 

Carvalho FLF, Simons BW, Eberhart CG, Berman DM (2014) Notch signaling in prostate cancer: a moving target. Prostate 74(9):933–945

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chiba S (2006) Concise review: Notch signaling in stem cell systems. Stem Cells 24(11):2437–2447

Article  CAS  PubMed  Google Scholar 

Chou T-C (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70(2):440–446

Article  CAS  PubMed  Google Scholar 

Ciniglia C, Pinto G, Sansone C, Pollio A (2010) Acridine orange/ethidium bromide double staining test: a simple in-vitro assay to detect apoptosis induced by phenolic compounds in plant cells. Allelopath J 26(2):301–308

Google Scholar 

Cragg GM, Newman DJ (2000) Antineoplastic agents from natural sources: achievements and future directions. Expert Opin Investig Drugs 9(12):2783–2797

Article  CAS  PubMed  Google Scholar 

Dasari S, Njiki S, Mbemi A, Yedjou CG, Tchounwou PB (2022) Pharmacological effects of cisplatin combination with natural products in cancer chemotherapy. Int J Mol Sci 23(3):1532

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dos Santos NAG, Ferreira RS, Dos Santos AC (2020) Overview of cisplatin-induced neurotoxicity and ototoxicity, and the protective agents. Food Chem Toxicol 136:111079

Article  PubMed  Google Scholar 

Edmunds K, Tuffaha H, Galvão DA, Scuffham P, Newton RU (2020) Incidence of the adverse effects of androgen deprivation therapy for prostate cancer: a systematic literature review. Support Care Cancer 28:2079–2093

Article  PubMed  Google Scholar 

Elgendy AE (2019) Synergistic curative effect of boswellic acid and cisplatin against diethyl nitrosamine-induced hepatocellular carcinoma. Benha Vet Med J 36(2):256–263

Article  Google Scholar 

Florea A-M, Büsselberg D (2011) Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel) 3(1):1351–1371

Article  CAS  PubMed  Google Scholar 

Galluzzi L, Vitale I, Michels J, Brenner C, Szabadkai G, Harel-Bellan A, Castedo M, Kroemer G (2014) Systems biology of cisplatin resistance: past, present and future. Cell Death Dis 5(5):e1257–e1257

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gumulec J, Balvan J, Sztalmachova M, Raudenska M, Dvorakova V, Knopfova L, Polanska H, Hudcova K, Ruttkay-Nedecky B, Babula P (2014) Cisplatin-resistant prostate cancer model: differences in antioxidant system, apoptosis and cell cycle. Int J Oncol 44(3):923–933

Article  CAS  PubMed  Google Scholar 

Hardie ME, Kava HW, Murray V (2016) Cisplatin analogues with an increased interaction with DNA: Prospects for therapy. Curr Pharm Des 22(44):6645–6664

Article  CAS  PubMed  Google Scholar 

Hasan A, Rizvi SF, Parveen S, Pathak N, Nazir A, Mir SS (2022) Crosstalk between ROS and autophagy in tumorigenesis: understanding the multifaceted paradox. Front Oncol 12:852424

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hassan F, El-Hiti GA, Abd-Allateef M, Yousif E (2017) Cytotoxicity anticancer activities of anastrozole against breast, liver hepatocellular, and prostate cancer cells. Saudi Med J 38(4):359

Article  PubMed  PubMed Central  Google Scholar 

Hongo H, Kosaka T, Oya M (2018) Analysis of cabazitaxel-resistant mechanism in human castration-resistant prostate cancer. Cancer Sci 109(9):2937–2945

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu Y-Y, Zheng M, Zhang R, Liang Y-M, Han H (2012) Notch signaling pathway and cancer metastasis. Notch Signal Embryol Cancer 186–198. https://doi.org/10.1007/978-1-4614-0899-4_14

Jaaks P, Coker EA, Vis DJ, Edwards O, Carpenter EF, Leto SM, Dwane L, Sassi F, Lightfoot H, Barthorpe S, van der Meer D, Yang W, Beck A, Mironenko T, Hall C, Hall J, Mali I, Richardson L, Tolley C, Morris J, Garnett MJ (2022) Effective drug combinations in breast, colon and pancreatic cancer cells. Nature 603(7899):166–173. https://doi.org/10.1038/s41586-022-04437-2

Article  CAS  PubMed  PubMed Central